Publication Date
11-13-2024
Journal
Cell Genomics
DOI
10.1016/j.xgen.2024.100674
PMID
39406235
PMCID
PMC11605692
PubMedCentral® Posted Date
10-14-2024
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Humans, DNA Methylation, Haplotypes, Neoplasms, Cohort Studies, Gene Rearrangement, Sequence Analysis, DNA, Promoter Regions, Genetic, High-Throughput Nucleotide Sequencing, MutL Protein Homolog 1, cancer genomics, nanopore long-read sequencing, structural variant detection, allelically differentially methylated regions (aDMRs), allele-specific expression, long-range phasing, homologous recombination deficiency, extrachromosomal DNA, personalized medicine, TFRI MOHCCN
Abstract
The Long-Read Personalized OncoGenomics (POG) dataset comprises a cohort of 189 patient tumors and 41 matched normal samples sequenced using the Oxford Nanopore Technologies PromethION platform. This dataset from the POG program and the Marathon of Hope Cancer Centres Network includes DNA and RNA short-read sequence data, analytics, and clinical information. We show the potential of long-read sequencing for resolving complex cancer-related structural variants, viral integrations, and extrachromosomal circular DNA. Long-range phasing facilitates the discovery of allelically differentially methylated regions (aDMRs) and allele-specific expression, including recurrent aDMRs in the cancer genes RET and CDKN2A. Germline promoter methylation in MLH1 can be directly observed in Lynch syndrome. Promoter methylation in BRCA1 and RAD51C is a likely driver behind homologous recombination deficiency where no coding driver mutation was found. This dataset demonstrates applications for long-read sequencing in precision medicine and is available as a resource for developing analytical approaches using this technology.
Graphical Abstract
Included in
Biological Phenomena, Cell Phenomena, and Immunity Commons, Biomedical Informatics Commons, Genetics and Genomics Commons, Medical Genetics Commons, Medical Molecular Biology Commons, Medical Specialties Commons, Neoplasms Commons